L & S Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Buy
75,255
+33,789
+81% +$4.73M 1.32% 20
2025
Q4
$5.09M Buy
+41,466
New +$5.04M 0.47% 61
2025
Q2
Sell
-65,246
Closed -$7.31M 353
2025
Q1
$7.31M Buy
+65,246
New +$6.73M 0.9% 25
2018
Q4
Sell
-13,089
Closed -$1.01M 311
2018
Q3
$1.01M Buy
+13,089
New +$989K 0.13% 141
2017
Q4
Sell
-88,531
Closed -$7.17M 319
2017
Q3
$7.17M Buy
+88,531
New +$6.77M 1.2% 16
2016
Q1
Sell
-37,782
Closed -$3.82M 86
2015
Q4
$3.82M Sell
37,782
-1,256
-3% -$131K 0.96% 44
2015
Q3
$3.83M Sell
39,038
-1,853
-5% -$206K 1.11% 37
2015
Q2
$4.79M Buy
40,891
+53
+0.1% +$5.79K 1.22% 31
2015
Q1
$4.01M Buy
+40,838
New +$4.15M 1.06% 40
2014
Q4
Sell
-18,310
Closed -$1.95M 80
2014
Q3
$1.95M Buy
+18,310
New +$1.79M 0.95% 22
2014
Q2
Sell
-28,410
Closed -$2.01M 89
2014
Q1
$2.01M Sell
28,410
-46,074
-62% -$3.61M 1.07% 43
2013
Q4
$5.59M Sell
74,484
-19,562
-21% -$1.36M 2.03% 8
2013
Q3
$5.91M Sell
94,046
-2,942
-3% -$176K 2.39% 3
2013
Q2
$4.97M Buy
+96,988
New +$5.06M 2.43% 11

Other funds holding GILD

L & S Advisors's GILD Position: Q1 2026 in Review

L & S Advisors increased its Gilead Sciences (GILD) stake by 81% in Q1 2026, buying an estimated $4.73M and bringing the position to 75,255 shares worth $10.5M. The position accounts for 1.32% of the portfolio, ranked #20.

L & S Advisors first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • L & S Advisors held 75,255 shares of Gilead Sciences worth $10.5M as of Q1 2026.
  • L & S Advisors bought 33,789 Gilead Sciences shares in Q1 2026, an estimated $4.73M.
  • Gilead Sciences made up 1.32% of L & S Advisors's portfolio in Q1 2026, its #20 holding.
  • L & S Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on L & S Advisors's 13F filing for Q1 2026, filed 11 May 2026.